Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03455764
Title MCS110 With BRAF/MEK Inhibition in Patients With Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST